KYMR
Price
$74.64
Change
+$1.95 (+2.68%)
Updated
Feb 2, 11:56 AM (EDT)
Capitalization
5.82B
17 days until earnings call
Intraday BUY SELL Signals
WVE
Price
$12.94
Change
-$0.07 (-0.54%)
Updated
Jan 30 closing price
Capitalization
2.41B
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs WVE

Header iconKYMR vs WVE Comparison
Open Charts KYMR vs WVEBanner chart's image
Kymera Therapeutics
Price$74.64
Change+$1.95 (+2.68%)
Volume$100
Capitalization5.82B
Wave Life Sciences
Price$12.94
Change-$0.07 (-0.54%)
Volume$2.33M
Capitalization2.41B
KYMR vs WVE Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. WVE commentary
Feb 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and WVE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 02, 2026
Stock price -- (KYMR: $72.69 vs. WVE: $12.94)
Brand notoriety: KYMR and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 88% vs. WVE: 27%
Market capitalization -- KYMR: $5.82B vs. WVE: $2.41B
KYMR [@Biotechnology] is valued at $5.82B. WVE’s [@Biotechnology] market capitalization is $2.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, WVE is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 5 TA indicator(s) are bullish while WVE’s TA Score has 3 bullish TA indicator(s).

  • KYMR’s TA Score: 5 bullish, 4 bearish.
  • WVE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than WVE.

Price Growth

KYMR (@Biotechnology) experienced а +3.95% price change this week, while WVE (@Biotechnology) price change was -3.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was +5.11%, and the average quarterly price growth was +35.35%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

WVE is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (-0.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($5.82B) has a higher market cap than WVE($2.41B). KYMR YTD gains are higher at: -6.580 vs. WVE (-23.882). WVE has higher annual earnings (EBITDA): -127.2M vs. KYMR (-286.52M). KYMR has more cash in the bank: 506M vs. WVE (196M). WVE has less debt than KYMR: WVE (19.8M) vs KYMR (84M). WVE has higher revenues than KYMR: WVE (109M) vs KYMR (43.7M).
KYMRWVEKYMR / WVE
Capitalization5.82B2.41B242%
EBITDA-286.52M-127.2M225%
Gain YTD-6.580-23.88228%
P/E RatioN/AN/A-
Revenue43.7M109M40%
Total Cash506M196M258%
Total Debt84M19.8M424%
FUNDAMENTALS RATINGS
WVE: Fundamental Ratings
WVE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRWVE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 13 days ago
76%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
WVE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GACCX30.06-0.12
-0.40%
Gabelli Global Rising Income and Div C
BRUKX16.41-0.09
-0.55%
MFS Blended Research Value Equity R2
AEDAX35.27-0.32
-0.90%
Invesco International Value A
FGIGX47.58-0.61
-1.27%
American Funds Intl Gr and Inc529-F-3
GERAX12.39-0.27
-2.13%
Goldman Sachs Em Mkts Eq Insghts A

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.65%
NRIX - KYMR
65%
Loosely correlated
-6.08%
WVE - KYMR
55%
Loosely correlated
-0.54%
VERA - KYMR
54%
Loosely correlated
-3.87%
OCUL - KYMR
52%
Loosely correlated
-8.14%
GPCR - KYMR
50%
Loosely correlated
+1.49%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been closely correlated with GPCR. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if WVE jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
-0.54%
GPCR - WVE
69%
Closely correlated
+1.49%
FULC - WVE
55%
Loosely correlated
-1.92%
KYMR - WVE
55%
Loosely correlated
-1.65%
OCUL - WVE
54%
Loosely correlated
-8.14%
NRIX - WVE
45%
Loosely correlated
-6.08%
More